Zimmer Biomet Holdings Inc. (ZBH)
NYSE: ZBHHealth CareIndustrial SpecialtiesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ZBH stock chart
Technical analysisKey statistics
All statistics- Market cap
- $16.88B
- P/E (TTM)
- 21.48
- Forward P/E
- 9.76
- EPS (TTM)
- $4.12
- Dividend yield
- 1.08% ($0.96)
- Ex-dividend date
- Sep 30, 2026
- 52-week range
- 79.12 – 106.88
- Day range
- 88.32 – 90.01
- Volume / Avg
- 1.99M / 2.16M
- Beta
- —
- Shares outstanding
- 190.74M
- Next earnings
- Nov 4, 2026
52-week range
ZBH stock today
Zimmer Biomet (ZBH) closed at $88.49 on Oct 7, down 1.33% (-$1.19), versus the S&P 500's 0.22% decline. At this level, ZBH sits in the middle of its 52-week range of $79.12 to $106.88: 17.2% below the high, set on Oct 22, 2025 and 11.8% above the low. ZBH is down 1.6% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 10.7%.
At 21.5x trailing earnings, Zimmer Biomet trades in line with the peer-group median of 23.3x. Its forward P/E of 9.8x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Zimmer Biomet's next earnings report is expected on Nov 4, 2026. Zimmer Biomet pays an annual dividend of $0.96 per share, a 1.08% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Zimmer Biomet
Company profileZimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest.
- Sector
- Health Care
- Industry
- Industrial Specialties
- CEO
- Mr. Ivan Tornos
- Headquarters
- Warsaw, IN
- Employees
- 17,000
- Website
- zimmerbiomet.com
Financial highlights
Full financialsIn fiscal 2025, Zimmer Biomet generated $8.23 billion in revenue, up 7.2% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $705.1 million (-22.0% year over year), for a net margin of 8.6% versus a median of 5.9% in the prior 5 years. Gross margin was 69.7% (down from 71.5%) and operating margin 13.3%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B |
| Growth | +7.20% | +3.85% | +6.55% | +1.65% | +11.42% |
| Net income | $705.10M | $903.80M | $1.02B | $231.40M | $401.60M |
| EPS (diluted) | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 |
Analyst forecast
ForecastConsensus (28 analysts)
buy
Avg. price target
$107.23+21.18%
- Strong buy 3
- Buy 6
- Hold 19
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $1.89
- Last reported (Q2 2026)
- Aug 5, 2026
- EPS actual vs est.
- $1.03 vs —
Dividends
Dividend history- Annual dividend
- $0.96
- Dividend yield
- 1.08%
- Last payment
- $0.24
- Ex-dividend date
- Sep 30, 2026
ZBH news
All ZBH newsZimmer Biomet peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| STESTERIS plc (Ireland) | 209.68 | +0.49% | $20.44B | vs ZBH |
| MASMasco Corporation | 68.87 | -1.52% | $13.58B | vs ZBH |
| AITApplied Industrial Technologies Inc. | 334.58 | -3.02% | $12.29B | vs ZBH |
| SNNSmith & Nephew SNATS Inc. | 26.89 | +0.07% | $11.25B | vs ZBH |
| ALGNAlign Technology Inc. | 139.87 | -1.12% | $9.94B | vs ZBH |
| MSAMSA Safety Incorporated | 179.28 | -1.74% | $6.92B | vs ZBH |
| MTRNMaterion Corporation | 290.72 | -6.87% | $6.06B | vs ZBH |
| POOLPool Corporation | 154.14 | -2.59% | $5.60B | vs ZBH |
Indexes, lists and sector
Index membership
Appears in lists
Zimmer Biomet stock FAQ
What is Zimmer Biomet's stock price today?
ZBH last traded at $88.49 as of Oct 7, 4:00 PM EDT, down 1.33% on the day. Prices are delayed at least 15 minutes.
Does Zimmer Biomet pay a dividend?
Yes. Zimmer Biomet pays $0.96 per share annually, a 1.08% yield. The most recent dividend of $0.24 had an ex-dividend date of Sep 30, 2026.
When is Zimmer Biomet's next earnings date?
Zimmer Biomet is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $1.89.
What is ZBH's P/E ratio?
ZBH trades at a trailing P/E ratio of 21.48 and a forward P/E of 9.76, compared with a median of 23.3 for its closest peers.
Is Zimmer Biomet in the S&P 500?
Yes. Zimmer Biomet (ZBH) is a constituent of the S&P 500 index.
Who is Zimmer Biomet's CEO?
Mr. Ivan Tornos is the chief executive officer of Zimmer Biomet Holdings Inc., which has about 17,000 employees.
Has ZBH ever split its stock?
Yes. The most recent ZBH stock split was a 103-for-100 split on Mar 1, 2022.